Weekly Insulin Shots Match Daily Injections in Diabetes Management

Clinical trials reveal that once-weekly efsitora is as effective as daily insulin for controlling blood sugar in both Type 1 and Type 2 diabetes.

Two Phase 3 trials found that weekly efsitora injections control blood sugar as effectively as daily degludec insulin in both Type 1 and Type 2 diabetics.
Type 2 diabetics on efsitora showed similar HbA1c reductions to those on daily insulin, with fewer hypoglycemia events.
Type 1 diabetics on efsitora experienced higher rates of severe hypoglycemia compared to those on daily insulin, prompting calls for further dose evaluation.
Researchers suggest that weekly insulin could simplify diabetes management by reducing the frequency of injections and improving adherence.
The trials' promising results were presented at the European Association for the Study of Diabetes annual meeting and published in leading medical journals.